Incyte
INCY
#1169
Rank
โ‚น1.800 T
Marketcap
โ‚น9,171
Share price
-1.00%
Change (1 day)
42.87%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): โ‚น137.60 Billion

According to Incyte's latest financial reports the company's current earnings are โ‚น4.81 Billion. In 2024 the company made an earning of โ‚น29.01 Billion a decrease over its 2023 earnings that were of โ‚น76.44 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น137.60 B374.24%
2024 โ‚น29.01 B-62.04%
2023 โ‚น76.44 B57.66%
2022 โ‚น48.48 B-7.24%
2021 โ‚น52.27 B-345.65%
2020 -โ‚น21.29 Billion-147.7%
2019 โ‚น44.61 B322.02%
2018 โ‚น10.57 B-136.94%
2017 -โ‚น28.62 Billion-390.76%
2016 โ‚น9.84 B1322%
2015 โ‚น0.69 B-115.56%
2014 -โ‚น4.45 Billion-41.4%
2013 -โ‚น7.6 Billion87.67%
2012 -โ‚น4.05 Billion-74.9%
2011 -โ‚น16.12 Billion843.59%
2010 -โ‚น1.71 Billion-88.68%
2009 -โ‚น15.09 Billion1.37%
2008 -โ‚น14.89 Billion86.16%
2007 -โ‚น8 Billion17.64%
2006 -โ‚น6.8 Billion-28.62%
2005 -โ‚น9.53 Billion-36.1%
2004 -โ‚น14.91 Billion-2.03%
2003 -โ‚น15.22 Billion22.26%
2002 -โ‚น12.45 Billion-27.39%
2001 -โ‚น17.14 Billion198.72%
2000 -โ‚น5.74 Billion132.2%
1999 -โ‚น2.48 Billion-556.86%
1998 โ‚น0.54 B-37.23%
1997 โ‚น0.86 B-259.32%
1996 -โ‚น0.55 Billion-45.87%
1995 -โ‚น1 Billion-9.17%
1994 -โ‚น1.1 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.504 T 933.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น1.086 T 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.062 T 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น755.48 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น6.12 B-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น4.21 Billion-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น6.35 Billion-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น2.67 Billion-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น5.1 Billion-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA